Moreover, vismodegib, a SHH pathway inhibitor, decreases expression of GLI1 and Survivin, and promotes radiation-induced DNA damage in HNSCC cells [180]. This evidence concerns the gene GLI1 and head and neck squamous cell carcinoma.